{"id":"https://openalex.org/W246720194","doi":"https://doi.org/10.1017/cbo9780511730412.005","title":"Fragment-based structure-guided drug discovery: strategy, process, and lessons from human protein kinases","display_name":"Fragment-based structure-guided drug discovery: strategy, process, and lessons from human protein kinases","publication_year":2010,"publication_date":"2010-05-31","ids":{"openalex":"https://openalex.org/W246720194","doi":"https://doi.org/10.1017/cbo9780511730412.005","mag":"246720194"},"language":"en","primary_location":{"id":"doi:10.1017/cbo9780511730412.005","doi":"https://doi.org/10.1017/cbo9780511730412.005","is_oa":false,"landing_page_url":"https://doi.org/10.1017/cbo9780511730412.005","pdf_url":null,"source":{"id":"https://openalex.org/S4306462995","display_name":"Cambridge University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W1539372622","display_name":"Drug Design"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068648875","display_name":"Stephen Kevin Burley","orcid":"https://orcid.org/0000-0002-2487-9713","observed_orcids":["https://orcid.org/0000-0002-2487-9713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen K. Burley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059727608","display_name":"Gavin C. Hirst","orcid":"https://orcid.org/0009-0000-5614-8942","observed_orcids":["https://orcid.org/0009-0000-5614-8942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin Hirst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015619526","display_name":"Paul A. Sprengeler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Sprengeler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058385152","display_name":"Siegfried Reich","orcid":"https://orcid.org/0000-0002-6840-2618","observed_orcids":["https://orcid.org/0000-0002-6840-2618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Siegfried Reich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5678,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.76693767,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":null,"issue":null,"first_page":"30","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fragment-based-drug-discovery","display_name":"fragment-based drug discovery","score":0.9990000128746033},{"id":"https://openalex.org/keywords/protein-kinases","display_name":"protein kinases","score":0.8040000200271606},{"id":"https://openalex.org/keywords/fragment-condensation","display_name":"fragment condensation","score":0.6899999976158142},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7179999947547913},{"id":"https://openalex.org/keywords/fragment-based-screening","display_name":"fragment screening","score":0.5379999876022339},{"id":"https://openalex.org/keywords/fragment-hits","display_name":"fragment hits","score":0.421999990940094},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.6549999713897705},{"id":"https://openalex.org/keywords/drug-candidates","display_name":"drug candidates","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2776235265","wikidata":"https://www.wikidata.org/wiki/Q18392052","display_name":"Fragment (logic)","level":2,"score":0.7586628794670105},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6047424674034119},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5313571095466614},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.511795699596405},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4903535842895508},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.3752489387989044},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2832236886024475},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2560349702835083},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.14807376265525818},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1017/cbo9780511730412.005","doi":"https://doi.org/10.1017/cbo9780511730412.005","is_oa":false,"landing_page_url":"https://doi.org/10.1017/cbo9780511730412.005","pdf_url":null,"source":{"id":"https://openalex.org/S4306462995","display_name":"Cambridge University Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320306493","display_name":"Abbott Laboratories","ror":"https://ror.org/0052svj16"},{"id":"https://openalex.org/F4320332359","display_name":"Office of Science","ror":"https://ror.org/00mmn6b08"},{"id":"https://openalex.org/F4320337480","display_name":"Basic Energy Sciences","ror":"https://ror.org/05mg91w61"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1497843070","https://openalex.org/W1502177285","https://openalex.org/W1972091733","https://openalex.org/W1972821149","https://openalex.org/W1975293246","https://openalex.org/W1982417569","https://openalex.org/W1985953075","https://openalex.org/W1994923840","https://openalex.org/W1996100382","https://openalex.org/W1999711931","https://openalex.org/W1999968212","https://openalex.org/W2001054421","https://openalex.org/W2001641653","https://openalex.org/W2017254234","https://openalex.org/W2031422149","https://openalex.org/W2032353075","https://openalex.org/W2038617772","https://openalex.org/W2042338355","https://openalex.org/W2047710091","https://openalex.org/W2048682054","https://openalex.org/W2050535564","https://openalex.org/W2117643210","https://openalex.org/W2133321875","https://openalex.org/W2135732933","https://openalex.org/W2151028167","https://openalex.org/W4248107770"],"related_works":["https://openalex.org/W2146549829","https://openalex.org/W2028816469","https://openalex.org/W4411627800","https://openalex.org/W2134503191","https://openalex.org/W1980677713","https://openalex.org/W4391079484","https://openalex.org/W2145951586","https://openalex.org/W4294921043","https://openalex.org/W2341664092","https://openalex.org/W2011391967"],"abstract_inverted_index":{"INTRODUCTION":[0],"The":[1,57],"experimental":[2],"roots":[3],"of":[4,14,26,59,79,98,144,178,236],"fragment-based":[5,224],"drug":[6,159],"discovery":[7,160],"can":[8,226],"be":[9,52],"found":[10],"in":[11,91,182,240],"the":[12,21,92,176,203],"work":[13],"Petsko,":[15],"Ringe,":[16],"and":[17,107,130,141,149,173,209,218,238],"coworkers,":[18],"who":[19],"were":[20],"first":[22],"to":[23,44,63,134,147,191,198,205],"report":[24],"flooding":[25],"protein":[27],"crystals":[28],"with":[29,38],"small":[30],"organic":[31],"solutes":[32],"(e.g.,":[33],"compounds":[34],"such":[35,83],"as":[36,69,71,84,137],"benzene":[37],"ten":[39],"or":[40,86],"fewer":[41],"nonhydrogen":[42],"atoms)":[43],"identify":[45,150],"bound":[46,123],"functional":[47],"groups":[48],"that":[49,223],"might":[50],"ultimately":[51],"transformed":[53],"into":[54],"targeted":[55],"ligands.":[56],"concept":[58],"linking":[60,179],"fragments":[61,124,180],"together":[62,133],"increase":[64,135,206],"binding":[65,207],"affinity":[66,208],"was":[67,88,153],"described":[68,90],"early":[70,93],"1992":[72],"by":[73,111,115,127,139],"Verlinde":[74,140],"et":[75],"al.":[76],"Computational":[77],"screening":[78,100,129],"fragments,":[80],"using":[81],"tools":[82],"DOCK":[85],"MCSS,":[87],"also":[89,154],"1990s.":[94],"Pharmaceutical":[95],"industry":[96],"application":[97],"fragment":[99,151,196,199],"began":[101],"at":[102,156],"Abbott":[103],"Laboratories,":[104],"where":[105],"Fesik":[106,172],"coworkers":[108,174],"pioneered":[109],"\u201cSAR":[110],"NMR\u201d":[112],"(structure/activity":[113],"relationship":[114],"nuclear":[116],"magnetic":[117],"resonance).":[118],"In":[119],"this":[120],"spectroscopic":[121],"approach,":[122],"are":[125],"detected":[126],"NMR":[128],"subsequently":[131],"linked":[132],"affinity,":[136],"envisaged":[138],"coworkers.":[142],"Application":[143],"x-ray":[145],"crystallography":[146],"detect":[148],"hits":[152],"pursued":[155],"Abbott.":[157],"Fragment-based":[158],"has":[161],"now":[162],"been":[163],"under":[164],"way":[165],"for":[166,232],"more":[167],"than":[168],"a":[169],"decade.":[170],"Although":[171],"popularized":[175],"notion":[177],"(as":[181],"their":[183],"highly":[184],"successful":[185],"BCL-2":[186],"program),":[187],"tactical":[188],"emphasis":[189],"appears":[190],"have":[192,220],"largely":[193],"shifted":[194],"from":[195],"condensation":[197],"engineering":[200],"(or":[201],"growing":[202],"fragment)":[204],"selectivity.":[210],"Various":[211],"biotechnology":[212],"companies,":[213],"including":[214],"SGX":[215],"Pharmaceuticals,":[216],"Astex,":[217],"Plexxikon,":[219],"recently":[221],"demonstrated":[222],"approaches":[225],"indeed":[227],"produce":[228],"development":[229],"candidates":[230],"suitable":[231],"Phase":[233],"I":[234],"studies":[235],"safety":[237],"tolerability":[239],"patients":[241],"(www.clinicaltrials.gov).":[242]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}